These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 894742)

  • 1. Effect of immunomodulators on effector cells involved in antibody-dependent cellular cytotoxicity: Brief communication.
    Tagliabue A; Mantovani A; Polentarutti N; Vecchi A; Spreafico F
    J Natl Cancer Inst; 1977 Sep; 59(3):1019-22. PubMed ID: 894742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immunomodulators on thymocyte suppressive activity in mice.
    Anaclerio A; Conti G; Moras ML; Maconi A; Spreafico F
    Eur J Cancer (1965); 1978 Aug; 14(8):829-35. PubMed ID: 28950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies of the immunostimulating (paramunizing) effectiveness of BCG, levamisole, Corynebacterium parvum and preparations of pock viruses in various in vivo and in vitro tests].
    Mayr A; Büttner M; Pawlas S; Erfle V; Mayr B; Brunner R; Osterkorn K
    Zentralbl Veterinarmed B; 1986 Jun; 33(5):321-39. PubMed ID: 2430381
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunostimulation: synthetic and biological modulators of immunity.
    Fudenberg HH; Whitten HD
    Annu Rev Pharmacol Toxicol; 1984; 24():147-74. PubMed ID: 6203479
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression of hepatic biotransformations by chemical immunoadjuvants.
    Giampietri A; Puccetti P; Contessa AR
    J Immunopharmacol; 1981; 3(2):251-64. PubMed ID: 7338632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities.
    Piccoli M; Saito T; Chirigos MA
    Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadjuvant activity of pyran copolymer. I. Evidence for direct stimulation of T-lymphocytes and macrophages.
    Baird LG; Kaplan AM
    Cell Immunol; 1975 Dec; 20(2):167-76. PubMed ID: 1106874
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanisms.
    Mantovani A; Tagliabue A; Vecchi A; Spreafico F
    Eur J Cancer (1965); 1976 Feb; 12(2):113-23. PubMed ID: 1083341
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicity.
    Kiger N; Bruley-Rosset M; Huchet R; Mathe G
    Immunology; 1980 Nov; 41(3):687-94. PubMed ID: 6970164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM; Woods WA; Mohr SJ; Chirigos MA
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of activity of mouse natural killer (NK) cells by activated macrophages from mice treated with pyran copolymer.
    Santoni A; Riccardi C; Barlozzari T; Herberman RB
    Int J Cancer; 1980 Dec; 26(6):837-43. PubMed ID: 6452418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors.
    Fisher B; Linta J; Hanlon J; Saffer E
    J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis.
    Sher NA; Poplack DG; Blaese RM; Brown TM; Chaparas SD
    J Natl Cancer Inst; 1977 Jun; 58(6):1753-7. PubMed ID: 864753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoattractant properties of Corynebacterium parvum and pyran copolymer for human monocytes and neutrophils.
    Majeski JA; Stinnett JD
    J Natl Cancer Inst; 1977 Mar; 58(3):781-3. PubMed ID: 839571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
    Weinhold KJ; Bolognesi DP; Matthews TJ
    J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of various immunomodulators: independence from normal levels of circulating monocytes and natural killer cells.
    Morahan PS; Dempsey WL; Volkman A; Connor J
    Infect Immun; 1986 Jan; 51(1):87-93. PubMed ID: 2416693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity.
    Santoni A; Santoni G; Piccoli M; Herberman RB; Frati L
    Immunopharmacol Immunotoxicol; 1990; 12(3):363-87. PubMed ID: 2148342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.